SEARCH

Current Edition

Adagio

Adagio plans comeback for COVID drug, but is it too late?

Dive Brief: Adagio Therapeutics said it will ask the Food and Drug Administration for emergency authorization of its COVID-19 drug after announcing Wednesday that the antibody …

Continue Reading →
Adagio

Adagio pledges to press forward with COVID drug as CEO to resign

Dive Brief: Adagio Therapeutics CEO Tillman Gerngross has agreed “in principle” to resign as head of the COVID-19 drug developer amid confusion over whether its …

Continue Reading →
Adagio

Adagio, after bold promises, says antibody drug won’t work well against omicron

The findings are a huge disappointment for Adagio, which billed ADG20 as a weapon that could neutralize a wide range of variants and help with …

Continue Reading →